Nonpharmacologic Strategies to Modulate Nuclear Factor Erythroid 2-related Factor 2 Pathway in Chronic Kidney Disease

Marta Esgalhado1, Peter Stenvinkel2, Denise Mafra1

  • 1Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Rio de Janeiro (RJ), Brazil.

Insights

Nuclear factor erythroid 2-related factor 2 (Nrf2) activation combats oxidative stress and inflammation in chronic kidney disease (CKD). Nonpharmacologic strategies like diet and exercise show promise for Nrf2 modulation in CKD patients.

Area of Science:

  • Biochemistry
  • Cellular Biology
  • Nephrology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key regulator of cellular antioxidant and anti-inflammatory responses.
  • Oxidative stress and inflammation are major contributors to chronic kidney disease (CKD) progression and cardiovascular complications.
  • Nrf2 dysregulation is implicated in the pathophysiology of CKD.

Purpose of the Study:

  • To review nonpharmacologic strategies for modulating Nrf2 activation.
  • To explore the potential therapeutic benefits of Nrf2 activation in CKD patients.
  • To highlight the role of Nrf2 in mitigating oxidative stress and inflammation in CKD.

Main Methods:

  • Literature review of studies investigating Nrf2 activation.
  • Focus on nonpharmacologic interventions such as nutrition and physical exercise.
  • Analysis of Nrf2's role in cellular redox homeostasis and inflammatory pathways.

Main Results:

  • Nutritional components and physical exercise are identified as regulators of Nrf2 activation.
  • Limited research exists on Nrf2 modulation specifically within CKD patient populations.
  • Nrf2 activation demonstrates potential in preventing oxidative stress and maintaining cellular redox balance.

Conclusions:

  • Nonpharmacologic strategies hold promise for activating Nrf2 in CKD.
  • Targeting Nrf2 may offer a therapeutic avenue to reduce CKD complications, including cardiovascular disease.
  • Further research is needed to validate these strategies in CKD patients to improve health outcomes.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
558
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
505
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
829
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
906
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.4K